Overview
- Editors:
-
-
Anne H. Child
-
Cardiovascular & Cell Sciences Research, St George's, University of London, London, United Kingdom
Comprehensive multisystem coverage
Provides a summary of the present day understanding of diagnosis, management and best medical and surgical treatment of infants, children and adults with Marfan syndrome
Covers the lifelong problems from birth to old age, in each affected system?
Access this book
Other ways to access
Table of contents (27 chapters)
-
Front Matter
Pages i-xiii
-
-
-
- Don B. Wijetunge, Anne H. Child
Pages 13-19
-
-
-
- Yukiko Isekame, Sabiha Gati
Pages 39-55
-
- Anna Marciniak, Rajan Sharma
Pages 57-71
-
- Ee Ling Heng, Raad H. Mohiaddin
Pages 73-99
-
- Pouya Youssefi, Marjan Jahangiri
Pages 101-125
-
- Ruwan A. Weerakkody, Ulrich Rosendahl, Anthony L. Estrera, Hazim J. Safi, Nicholas J. Cheshire
Pages 127-140
-
- Aman Chandra, David G. Charteris
Pages 141-144
-
- Nanjundappa S. Harshavardhana, Mohammed H. H. Noordeen
Pages 145-164
-
- Anne H. Child, Rodney Grahame
Pages 165-167
-
-
- Anne H. Child, Anita K. Simonds
Pages 175-180
-
-
- Anne H. Child, Joanna Rowntree
Pages 185-187
-
- Benedict Scoones, Anne H. Child
Pages 189-200
-
- Timothy L. Jones, Marios C. Papadopoulos
Pages 201-217
About this book
This book has been written in response to the many excellent questions posed by our patients and their care teams, questions which deserve the best-informed and up to date answers provided by our experts in each of the many health areas affected by Marfan syndrome. The aim of this text is to provide a summary of the present day understanding of diagnosis, management and best medical and surgical treatment of infants, children and adults with Marfan syndrome. The authors cover the lifelong problems from birth to old age, in each affected system. Forty percent of this information is the result of new careful research based on a well-defined longitudinally studied UK patient population.
Reviews
“A multiauthor and multidisciplinary text on Marfan syndrome describes in 27 chapters the diagnosis, clinical, psycho-social and therapeutic aspects of this less rare than thought disease. To the best of my knowledge, the first book of its kind.” (Pediatric Endocrinology Reviews (PER), 2017)
“This book will be useful for all personnel involved in taking care of patients with Marfan syndrome … . This state-of-the-art book offers the most comprehensive collection of seminal knowledge about Marfan syndrome both in the pediatric and adult patient populations. It provides practice guidelines as well as step-by-step instructions on what to expect, what to do, what to avoid, and how to manage, patients with Marfan syndrome.” (Fahad Javed, Doody's Book Reviews, July, 2016)
Editors and Affiliations
-
Cardiovascular & Cell Sciences Research, St George's, University of London, London, United Kingdom
Anne H. Child
About the editor
Dr. Child is a University of Toronto Medical graduate who studied pediatrics, then Medical Genetics in Canada, USA, London (Hospital for Sick Children, Guy’s Hospital), before joining the Cardiac and Vascular Sciences Department, St. George’s, University of London, as Reader in Cardiovascular Genetics. She has a special interest in Marfan syndrome, with 25 years’ experience in diagnosis, management, and research into its many manifestations. She is an author of over 100 scientific papers. As organiser of the International Consortium to find the Marfan syndrome gene (fibrillin-1) in 1991, and a major contributor of over 200 genotype – phenotype correlations to the International Marfan Database held in Paris, she has an overview of clinical and molecular genetic studies. [Most importantly, she is genetic advisor to the national AIMS Trial of Irbesartan, involving 27 centres in the UK. This should determine whether Irbesartan is a medication which can preserve aortic wall architecture and prevent dissection.] Medical advisory links with the Marfan Association and the Marfan Trust (both of whom she helped to establish), have helped Dr Child to assemble a wealth of clinical and laboratory data, based on experience with over 3000 families with Marfan syndrome.
